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Transcription factor TFEB cell-
autonomously modulates 
susceptibility to intestinal epithelial 
cell injury in vivo
Tatsuro Murano1,3, Mehran Najibi1,5, Geraldine L. C. Paulus1,3, Fatemeh Adiliaghdam1,  
Aida Valencia-Guerrero2, Martin Selig4, Xiaofei Wang2, Kate Jeffrey1, Ramnik J. Xavier1,3,  
Kara G. Lassen1,3 & Javier E. Irazoqui  1,5
Understanding the transcription factors that modulate epithelial resistance to injury is necessary 
for understanding intestinal homeostasis and injury repair processes. Recently, transcription factor 
EB (TFEB) was implicated in expression of autophagy and host defense genes in nematodes and 
mammalian cells. However, the in vivo roles of TFEB in the mammalian intestinal epithelium were not 
known. Here, we used mice with a conditional deletion of Tfeb in the intestinal epithelium (TfebΔIEC) to 
examine its importance in defense against injury. Unperturbed TfebΔIEC mice exhibited grossly normal 
intestinal epithelia, except for a defect in Paneth cell granules. TfebΔIEC mice exhibited lower levels of 
lipoprotein ApoA1 expression, which is downregulated in Crohn’s disease patients and causally linked 
to colitis susceptibility. Upon environmental epithelial injury using dextran sodium sulfate (DSS), 
TfebΔIEC mice exhibited exaggerated colitis. Thus, our study reveals that TFEB is critical for resistance to 
intestinal epithelial cell injury, potentially mediated by APOA1.
The intestinal epithelium is the major site of interaction between the host and colonizing microbes. It is 
formed by one layer of intestinal epithelial cells, which include enterocytes, mucus-secreting goblet cells, 
antimicrobial-secreting Paneth cells, and hormone-secreting enteroendocrine (or chromaffin) cells. A major 
function is to provide a physical barrier to bacterial translocation into the host. An equally important function 
of intestinal epithelial cells is to secrete antimicrobial peptides and mucus that establish spatial segregation with 
the microbial population that resides in the lumen. A third important function is of surveillance of the lumen. 
Disruption of homeostasis in the lumen, by bacterial dysbiosis or chemical insult, results in the induction of genes 
that encode signaling molecules, which are secreted into the underlying stroma and recruit cells of the innate and 
adaptive immune systems1,2. Defective epithelial barrier function results in chronic activation of such responses, 
leading to inflammatory bowel disease and malignancy3.
Intestinal epithelial cells sense damage to the epithelial barrier as well as microbial products, which triggers 
changes in gene expression resulting in activation of the downstream host response to restore homeostasis4,5. 
Although the regulation of intestinal epithelial gene expression by such stimuli is considered a key event to pre-
serve and restore homeostasis, it is poorly understood. Previous studies have found roles for the NF-κB family 
of transcription factors that are triggered by engagement of TLR and NLR pattern recognition receptors2,6–8. 
However, it is likely that more complex transcriptional networks are important for the regulation of gene expres-
sion in the intestinal epithelium in response to environmental cues9,10.
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To discover transcription factors that are important for host defense in the intestinal epithelium, we previously 
followed an unbiased approach in the model organism C. elegans. We discovered that transcription factor TFEB 
(called HLH-30 in nematodes) is important for the induction of host defense genes in C. elegans infected with 
pathogenic bacteria11. TFEB was previously discovered as a transcription factor binding to the Eµ heavy chain 
immunoglobulin enhancer12, and important for the induction of CD40 ligand in T cells13. More recently, TFEB 
was identified as a key transcriptional activator of a large set of genes during cellular stress, including autophagy 
and lysosomal genes, known as the Coordinated Lysosomal Expression and Regulation (CLEAR) network14–16.
TFEB activity is regulated post-translationally. Phosphorylation of TFEB by mTORC1, ERK2, and GSK3 
results in its cytosolic retention16–18. Dephosphorylation of TFEB can be triggered by release of lysosomal Ca2+ 
and subsequent activation of protein phosphatase calcineurin, as well as by mTOR inhibition, causing its relo-
calization into the nucleus19. In our previous studies, we discovered that C. elegans HLH-30/TFEB controls the 
induction of genes with antimicrobial or cytoprotective functions, and that both classes of genes are required for 
host defense against infection. However, whether HLH-30/TFEB is required within the intestinal epithelium for 
this function is not known. We also showed that TFEB is required in murine macrophages for proper induction 
of several cytokines and chemokines after phagocytosis of Gram+ or Gram- bacterial pathogens, indicating that 
TFEB is a novel and evolutionarily conserved transcription factor in the host response to bacterial infection11,20. 
Based on this precedent, it is important to determine the functional importance of TFEB in barrier protection and 
repair in the mammalian intestinal epithelium.
To examine the biological roles of intestinal epithelial TFEB in vivo, we generated mice that lack intestinal 
epithelial TFEB. Conditional deletion of TFEB in the intestinal epithelium did not cause major abnormalities 
in ileal or colonic epithelium in unperturbed animals, except for abnormal Paneth cell secretory granules. In 
contrast, deletion of TFEB resulted in dramatically enhanced pathology during DSS-induced colitis, including 
increased local and systemic inflammation and bacterial translocation to distal tissues, concomitant with large 
gene expression changes in the intestinal epithelium compared to wild type animals. These strong effects of TFEB 
deletion reveal an important and previously unknown function for TFEB in resistance to injury to the intestinal 
epithelium.
Results
Intestinal epithelial TFEB is dispensable for baseline homeostasis. To determine the pattern of 
expression of TFEB in unperturbed animals, we performed anti-TFEB immunofluorescence in sections of the 
small intestine and colon of 8–12 week old mice of both sexes. We observed extensive TFEB expression through-
out both tissues (Fig. 1A). In the small intestine, TFEB expression was prominent in the epithelium proper along 
the crypt-villus axis, with higher expression in the crypts. TFEB was also expressed by unidentified cells in the 
lamina propria. While TFEB expression was apparent in the submucosa and adventitia, it was absent from the 
muscularis propria. Similarly, in the colon TFEB expression was mostly epithelial, submucosal, and adventitial. 
Furthermore, qRT-PCR of Tfeb mRNA from colon revealed that Tfeb mRNA is enriched in the epithelial cells 
compared to whole tissue (Fig. S1). These observations show that in the intestine, TFEB is expressed mainly in 
the epithelium.
To investigate the biological importance of TFEB expression in the intestinal epithelium, we undertook loss of 
function studies. Tfeb-knockout mice exhibit embryonic lethality21. Therefore, to generate mice that lack intesti-
nal epithelial TFEB expression, we bred Tfebflox/flox mice with mice that express the site-specific recombinase Cre 
from the villin promoter (villin-Cre mice)18. The resulting Tfebflox/flox homozygous, villin-Cre heterozygous double 
mutants (TfebΔIEC mice) lack detectable TFEB expression in the intestinal epithelium (Fig. 1B,C). In terms of 
growth, size, weight, external appearance, and behavior, TfebΔIEC mice were indistinguishable from their Tfebflox/
flox littermates. Assessment of small intestine and colon from TfebΔIEC mice revealed normal histology compared 
to age-matched, Tfebflox/flox littermates (Fig. 1D), regardless of sex. Furthermore, there were no obvious differences 
in cell proliferation in either small intestine (Fig. 1E,F) or colon (not shown), as measured by Ki-67 immuno-
fluorescence of tissue sections, nor in goblet cell numbers, as measured using Periodic-acid Schiff (PAS) stain 
(Fig. 1G,H). Thus, we concluded that TFEB is dispensable for normal morphology, proliferation, and differenti-
ation in the intestinal epithelium.
Loss of epithelial TFEB exacerbates DSS-induced colitis. To investigate the importance of epithelial 
TFEB during intestinal distress, we used DSS as a method to perturb homeostasis22. In this method, we induced 
chemical injury to the epithelium in gender-matched littermate mice with low-dose DSS for 5 days, followed 
by a recovery period of 6 days. We monitored body weight and disease activity index, a quantitative measure of 
colitis, over the entire time course (see Methods). TfebΔIEC mice exhibited dramatically enhanced body weight loss 
(Fig. 2A) and disease activity index (Fig. 2B), suggesting that DSS treatment caused much greater inflammation 
in TfebΔIEC animals than in Tfebflox/flox controls. Consistent with this interpretation, the colons of TfebΔIEC animals 
were much shorter than those from control mice after completion of the time course (Fig. 2C,D). Fecal Lipocalin 
2 is a sensitive biomarker for intestinal inflammation in inflammatory bowel diseases23 and rapidly increases after 
DSS treatment in mouse models24. We observed a significantly greater increase in fecal Lipocalin 2 in TfebΔIEC 
animals compared to Tfebflox/flox controls at 3 and 7 days after DSS treatment (Fig. 2E). Furthermore, even after 
the recovery phase, TfebΔIEC mice exhibited profound epithelial damage in colonic tissue, with a marked decrease 
in the number of crypts, severe infiltration of immune cells, and a much greater histological pathology score 
(Fig. 2F,G). These observations confirmed that inflammation after injury in animals that lacked TFEB in the intes-
tinal epithelium was enhanced and persistent, suggesting that TFEB plays a critical role in the protection and/or 
recovery of intestinal epithelial cells from injury.
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Epithelial TFEB is required for restoration of the epithelial barrier. To gain further insight into the 
consequences of TFEB deletion, we examined the expression of pro-inflammatory cytokines in colon tissue of 
animals at the end of the recovery phase (day 11). Using qRT-PCR, we observed increased expression of genes 
Il1b and Il6, which encode IL-1β and IL-6, respectively, in TfebΔIEC colons (Fig. 3A,B). In contrast, the expression 
of Ifng (IFN-γ) and Il17 (IL-17) remained unaffected by TFEB status (Fig. 3C,D). These results suggested that 
TfebΔIEC animals specifically exhibit greater expression of pro-inflammatory mediators IL-1β and IL-6. We also 
detected higher IL-1β protein levels in spleens of TfebΔIEC animals (Fig. 3E), suggesting that they develop greater 
systemic as well as local inflammation. Consistent with this idea, TfebΔIEC animals displayed enlarged spleens after 
recovery from DSS (Fig. 3F). Collectively, these data support a role for TFEB expressed in IECs to limit inflamma-
tion, and thus to affect the healing of the intestinal epithelial barrier after injury.
After the recovery phase, we measured bacterial endotoxin in the serum, which provides a quantitative meas-
ure of impaired intestinal barrier integrity and translocation of microbial products into the bloodstream. Serum 
endotoxin levels in untreated TfebΔIEC and Tfebflox/flox animals were not significantly different, indicating the 
absence of major defects in intestinal permeability at baseline (Fig. 3G). During DSS administration, serum LPS 
levels increase22. As previously shown in wild type mice25, serum endotoxin levels returned to normal in Tfebflox/
flox control mice after the recovery phase (Fig. 3G). In contrast, TfebΔIEC animals still exhibited three times the 
normal level of endotoxin during the recovery phase, suggesting that barrier function had not been fully restored 
(Fig. 3G). Consistent with this result, commensal bacterial translocation to the spleen and the mesenteric lymph 
nodes remained almost 2 logs higher in the TfebΔIEC animals compared to Tfebflox/flox controls (Fig. 3H,I). These 
mice also exhibited significantly increased levels of FITC-dextran in the serum after gavage, consistent with a per-
sistent disruption of the intestinal epithelial barrier of TfebΔIEC mice after recovery from DSS treatment (Fig. 3J). 
These results indicate that epithelial TFEB is critical for barrier restoration after epithelial injury.
Defective Paneth cells in TfebΔIEC animals. Intestinal immune homeostasis is maintained in part by 
specialized secretory epithelial cells that reside in the crypts of the small intestine, known as Paneth cells26. A 
major function of Paneth cell is to secrete antimicrobial peptides, including α defensins (or cryptdins), lysozyme, 
and phospholipase A1. α defensins are mostly expressed in the small intestine27, but are functional in the 
colon28. Paneth cell defects and reduced α defensin expression have been linked to inflammatory bowel disease 
Figure 1. TfebΔIEC animals exhibit normal gut morphology. (A) Anti-TFEB immunofluorescence of small 
intestine (Top) or colon (Bottom). (B) Anti-TFEB immunoblot of whole cell extracts showing undetectable 
levels of TFEB in the enterocytes of TfebΔIEC animals. (C) Anti-TFEB immunofluorescence of colonic crypts. 
(D) H&E staining of sections of small intestine (Top) and colon (Bottom) of TfebΔIEC and Tfebflox/flox animals. 
Scale bars represent 100 μm. (E) Anti-Ki-67 immunofluorescence of small intestine of TfebΔIEC and Tfebflox/flox 
animals. Scale bars represent 100 μm. (F) Quantification of Ki-67 immunofluorescence. N = 4 each. Data are 
means, error bars are S.E.M. ns, not significant (Student’s t-test). (G) PAS staining of small intestine sections of 
TfebΔIEC and Tfebflox/flox animals. Scale bars represent 100 μm. (H) Quantification of goblet cells per ileal crypt. 
N = 3 mice per genotype and at least 20 crytps were scored for each mouse. Data are means, error bars are 
S.E.M. ns, not significant (Student’s t test).
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in humans29–33 and to enhanced susceptibility to DSS-induced colitis in mice34,35. Therefore, we examined the 
phenotype of Paneth cells in TfebΔIEC animals. Lysozyme immunofluorescence staining revealed no gross dif-
ferences in Paneth cell number, organization, or morphology between TfebΔIEC and Tfebflox/flox animals at base-
line (Fig. 4A,B). In contrast, ultrastructural examination of intracellular secretory granules using transmission 
electron microscopy revealed a defect in TfebΔIEC Paneth cells. While the granules in Tfebflox/flox Paneth cells pre-
sented the expected electron-dense material tightly surrounded by membrane, TfebΔIEC Paneth cells presented 
abnormal granule morphology, characterized by partial filling of the membrane-bound compartment, suggestive 
of a granule biogenesis defect (Fig. 4C,D). Similar Paneth cell granule defects had been previously observed in 
Atg4B-deficient mice34, suggesting that deletion of TFEB in IECs may affect a related mechanism at baseline. 
These results indicate that epithelial expression of TFEB is required for proper assembly of Paneth cell secretory 
granules.
Based on these findings in Paneth cells, we examined the distal small intestine tissue after recovery from DSS 
injury. Histologic assessment confirmed more severe histopathology in distal small intestine of TfebΔIEC mice at 
day 11 (Fig. 4E,F). At baseline and after the recovery phase of DSS colitis, Tfebflox/flox animals had similar numbers 
of lysozyme+ Paneth cells in the ileum, as evidenced by anti-lysozyme staining. In contrast, TfebΔIEC animals 
lacked lysozyme+ Paneth cells in the ileum after the recovery phase (Fig. 4G,H), suggesting that epithelial TFEB 
is essential for Paneth cell survival and restitution after intestinal injury.
Loss of epithelial TFEB results in minor transcriptional defects at baseline, major changes 
during injury. To determine the transcriptional effects of loss of TFEB function, we characterized the tran-
scriptomes of colonic epithelial cells from Tfebflox/flox and TfebΔIEC animals by RNA-seq. At the end of the DSS 
administration (Day 4) and after the recovery period (Day 11), a large set (360 genes) were significantly down-
regulated in TfebΔIEC animals compared to Tfebflox/flox controls (Fig. 5A, Table S1). The majority of these transcrip-
tomic differences between TfebΔIEC and Tfebflox/flox animals persisted after the recovery phase (Day 11), consistent 
Figure 2. Epithelial deletion of TFEB results in greatly enhanced susceptibility to DSS-induced colitis. (A) Body 
weight and (B). Disease activity index as a function of time. Tfebflox/flox mice N = 8, TfebΔIEC mice N = 5. Data are 
means, error bars are S.E.M. **p < 0.01, ***p < 0.001, ****p < 0.0001 (two-way ANOVA test). Representative 
of two independent trials. (C) Colonic lengths and spleen sizes of representative TfebΔIEC and Tfebflox/flox animals 
at Day 11. (D) Quantification of colon length. Tfebflox/flox mice N = 8, TfebΔIEC mice N = 5. Data are means, error 
bars are S.E.M. ***p < 0.001 (two-sample t test). (E) Stool Lipocalin 2 (LCN2) as a function of time. Tfebflox/flox 
mice N = 8, TfebΔIEC mice N = 5. Data are means, error bars are S.E.M. **p < 0.01, ****p < 0.0001 (two-way 
ANOVA test). (F) H&E staining of colonic sections of representative TfebΔIEC and Tfebflox/flox animals at Day 11. 
Scale bars represent 50 μm. (G) Colon histology score at Day 11. Tfebflox/flox mice N = 12, TfebΔIEC mice N = 10. 
Data are means, error bars are S.E.M. **p < 0.01 (two-sample t test).
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with our observation of the large recovery defect in the TfebΔIEC animals. Hierarchical clustering analysis segre-
gated the downregulated genes into two main clusters. The first cluster contained 296 genes downregulated in the 
4-fold to 500-fold range. Gene ontology annotations related to Mitochondria, Ribosome, and Translation were 
significantly enriched in this cluster (Table S2). The second cluster contained 64 genes that were not detected in 
the TfebΔIEC animals. These included α defensin genes Defa21, Defa25, and Defa26, in addition to Tfeb. As men-
tioned, defensins are antimicrobial peptides mostly secreted by Paneth cells that play a critical role in shaping the 
microbiome. Proper expression of defensins is required for intestinal homeostasis, and their disruption is linked 
to dysbiosis36. qRT-PCR confirmed lower Defa25 and Defa26 expression in epithelial cells of TfebΔIEC animals 
compared to Tfebflox/flox animals at Day 11 after DSS treatment (Fig. 5B,C). These results support the hypothesis 
that TFEB is required for proper defensin gene expression after epithelial injury, and are consistent with the 
observed secretory granule defect at baseline and absence of Paneth cells after recovery in TfebΔIEC animals.
Conversely, 564 genes were significantly upregulated in TfebΔIEC animals compared with Tfebflox/flox controls, 
during DSS induction and recovery (Fig. 5A, Table S1). These segregated into two clusters as well; 217 genes that 
were not detected in the Tfebflox/flox animals, and 347 that were upregulated in TfebΔIEC animals in the 4 to 500-fold 
range. In the latter category, we identified genes involved in autophagy (Irgm1, Sqstm1), in the endoplasmic 
reticulum unfolded protein response (Xbp1), and in lysosomal function (Cathepsin genes Ctsa, Ctsb, and Ctsc, 
mannose-6-phosphate receptor M6pr, and β-hexosaminidase subunit β Hexb). Only the latter cluster exhibited 
enrichment of gene ontology annotation categories, which were related to adherens junctions, vesicle/vacuole/
lysosome, mitochondria, and the endoplasmic reticulum (Table S2). Taken together, these findings surprisingly 
showed no defect in the expression of lysosomal and autophagy genes in TfebΔIEC animals, and suggested that 
unknown cellular mechanisms may be activated to compensate for the loss of TFEB within intestinal epithelial 
cells. These putative compensatory mechanisms may induce the expression of innate immunity, cell adhesion, and 
organelle genes in an attempt to restore tissue homeostasis. Alternatively, the observed gene induction could be 
secondary to the enhanced inflammatory infiltration caused by loss of TFEB.
In contrast to these large differences during and after DSS treatment, there were few differentially expressed 
genes between unperturbed Tfebflox/flox and TfebΔIEC animals (Fig. 6A, Table S1). Just 21 genes were significantly 
downregulated in TfebΔIEC animals compared to Tfebflox/flox controls, yet none of these were known autophagy or 
lysosomal biogenesis genes. This suggested the unexpected conclusion that TFEB is dispensable in the colonic 
epithelium for autophagy and lysosomal gene expression at baseline.
ApoA1 encodes apolipoprotein A1, which is the major constituent of high density lipoprotein (HDL)37. 
APOA1 in HDL is important for the transport of cholesterol and phospholipids from the periphery to the 
liver. Importantly, deficiency in human APOA1 expression has been linked to susceptibility to inflammatory 
bowel disease in humans38,39. Furthermore, loss of intestinal ApoA1 results in greatly enhanced susceptibility to 
DSS-induced colitis and malignant transformation in mice40. In fact, overexpression of human APOA1 protects 
mice from DSS colitis41. These previous studies establish causality between APOA1 expression and intestinal 
Figure 3. Increased inflammation and bacterial translocation in TfebΔIEC animals. (A–D) qRT-PCR from 
colonic tissue of genes Il1b (a), Il6 (b), Ifng (c), and Il17 (d) relative to reference gene Hprt. Data are means of 
three biological replicates, error bars are S.E.M. *p < 0.05 (two-sample t test). (E) Il-1β ELISA using splenic 
extracts from TfebΔIEC and Tfebflox/flox animals. Tfebflox/flox mice N = 8, TfebΔIEC mice N = 5. Data are means, 
error bars are S.E.M. **p < 0.01 (two-sample t test). (F) Splenic weights from TfebΔIEC and Tfebflox/flox animals. 
Data are means, error bars are S.E.M. **p < 0.01 (two-sample t test). (G) Baseline and day 11 serum endotoxin 
levels. Data are means, error bars are S.E.M. **p < 0.01 (two-sample t test). (H,I) Bacterial colony-forming 
units (CFU) per g of tissue in spleens (H) and mesenteric lymph nodes (I). Tfebflox/flox mice N = 7, TfebΔIEC mice 
N = 5 (H). Tfebflox/flox mice N = 8, TfebΔIEC mice N = 5 (I). Data are means, error bars are S.E.M. **p < 0.01 (two-
sample t test). (J) Intestinal permeability measured by FITC dextran in serum. Tfebflox/flox mice N = 7, TfebΔIEC 
mice N = 5. Data are means, error bars are S.E.M. **p < 0.01 (two-sample t test).
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inflammation. Strikingly, ApoA1 was strongly downregulated in TfebΔIEC animals (Fig. 6A), suggesting that 
APOA1 could contribute to TFEB-mediated epithelial protection.
Defective APOA1 expression in TfebΔIEC animals. Using qRT-PCR, we confirmed that intestinal 
epithelial cells from unperturbed TfebΔIEC animals express much lower ApoA1 mRNA than Tfebflox/flox animals 
(Fig. 6B). Immunofluorescence staining for APOA1 revealed a major reduction in epithelial APOA1 in unper-
turbed animals (Fig. 6C,D). After recovery from DSS colitis, while Tfebflox/flox animals exhibited reduced but 
detectable APOA1 expression, APOA1 expression in TfebΔIEC animals was lost (Fig. 6C,D). These results demon-
strate a severe reduction in APOA1 expression caused by TFEB deficiency in the intestinal epithelium at baseline 
and after recovery from injury. Such defects in APOA1 expression could provide a mechanistic basis for the 
greatly enhanced susceptibility of TfebΔIEC animals to chemically-induced colitis.
Figure 4. Paneth cell abnormalities in TfebΔIEC animals. (A) Lysozyme staining by immunofluorescence in 
small intestine of representative TfebΔIEC and Tfebflox/flox animals at baseline. Scale bars represent 100 μm. (B) 
Quantification of Paneth cells per crypt. Data are means, error bars are S.E.M. (C) Transmission electron 
microscopy of representative Paneth cells in TfebΔIEC and Tfebflox/flox animals. Scale bars: 5 µm (Top), 1 µm 
(Bottom). (D) Quantification of Paneth cell granule abnormality. N = 12 cells per genotype. Data are means, 
error bars are S.E.M. (E) H&E staining of small intestine sections from representative TfebΔIEC and Tfebflox/
flox animals at day 11. Scale bars, 100 µm. (F) Ileal histology score at day 11. Tfebflox/flox mice N = 7, TfebΔIEC 
mice N = 5. Data are means, error bars are S.E.M. (G) Lysozyme immunofluorescence in small intestine of 
representative TfebΔIEC and Tfebflox/flox animals at baseline and Day 11. Scale bars, 100 µm. (H) Quantification of 
lysozyme staining in TfebΔIEC and Tfebflox/flox animals as shown in f. Data are means, error bars are S.E.M. ns, not 
significant, *p < 0.05, ***p < 0.001, ****p < 0.0001 (two-sample t test).
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Figure 5. Transcriptional defects in enterocytes from DSS-treated TfebΔIEC animals. (A) Differentially 
expressed genes at days 4 and 11. Over-represented GO annotations are indicated to the right of the respective 
clusters. (B,C) qRT-PCR of Defa25 (c) and Defa26 (d) relative to reference gene Gapdh in TfebΔIEC and 
Tfebflox/flox animals at day 11. Tfebflox/flox mice N = 7, TfebΔIEC mice N = 5. Data are means, error bars are S.E.M. 
**p < 0.01, (two-sample t test).
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Figure 6. Transcriptional defects in enterocytes from unperturbed TfebΔIEC animals. (A) Differentially 
expressed genes at day 0 (untreated), comparing TfebΔIEC to Tfebflox/flox animals as reference. (B) qRT-PCR 
of ApoA1 relative to reference gene Gapdh in TfebΔIEC and Tfebflox/flox animals at baseline. Tfebflox/flox mice 
N = 6, TfebΔIEC mice N = 6. ****p < 0.0001 (two-sample t test). (C) Anti-APOA1 immunofluorescence in 
representative TfebΔIEC and Tfebflox/flox animals at baseline and day 11. Scale bars, 100 µm. (D) Quantification of 
anti-APOA1 immunofluorescence. ***p < 0.001, ****p < 0.0001 (two-way ANOVA test). (E) Working model 
for the observed TFEB-dependent decreased transcription of genes at baseline (left) and during colitis (right). 
The arrows connecting TFEB to each gene/category are not meant to imply direct regulation.
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Discussion
We report here the first functional analysis of TFEB in the intestinal epithelium, and identify TFEB as a critical 
determinant of susceptibility to epithelial injury. We found that TFEB is constitutively expressed in intestinal epi-
thelial cells in healthy animals. Conditional deletion of TFEB in the intestinal epithelium resulted in alterations to 
the Paneth cell compartment of the small intestine, and in minor transcriptional changes in colonic epithelial cells 
at baseline. Of note, ApoA1 expression was significantly downregulated at baseline in TfebΔIEC animals (Fig. 5H). 
The lack of a major transcriptional effect of TFEB deletion on the expression of genes in intestinal epithelial cells 
of unperturbed animals suggests that TFEB is not strongly engaged under baseline homeostatic conditions. This is 
consistent with our finding that TFEB localizes primarily to the cytosol of the intestinal epithelial cells in healthy 
animals, because cytosolic retention of TFEB is a major mode of its regulation42.
Animals lacking TFEB in the intestinal epithelium were much more susceptible to intestinal injury compared 
to control animals. Conditional deletion of epithelial TFEB resulted in greatly enhanced pathology through-
out the entire intestine after DSS treatment, as measured by several parameters, including cytokine expression, 
body weight loss, disease severity, and markers of inflammation in stool. The epithelial barrier exhibited more 
severe breakdown, as evidenced by increased permeability and bacterial translocation to distal organs. During 
the recovery phase, wild type mice were able to recover and repair the damage to the epithelium while condition-
ally deleted animals were unable to do so. These observations reveal a key role for TFEB deletion in the ability to 
protect the epithelium from chemical injury, and to repair the damage caused by the resulting exuberant inflam-
matory response.
Transcriptional profiling revealed a profound effect of TFEB deletion on the transcriptome of colonic entero-
cytes in DSS-treated animals (Fig. 6E). Among the downregulated genes, the notable absence of autophagy or 
lysosomal genes indicates that TFEB is not required for their expression in the intestinal epithelium, which is 
in stark contrast to other cell types, including HeLa cells and hepatocytes16. In contrast, the α defensin genes 
Defa25 and Defa26 were strongly dependent on TFEB. Defensins are antimicrobial peptides expressed by the 
intestinal epithelium, and are known to play important roles in intestinal homeostasis and host defense against 
infection43. Our results suggested that Tfeb is required for the expression of a subset of α defensin genes. These 
results are consistent with the striking defect in Paneth cell secretory granule morphology, and collectively sug-
gest an important role for Tfeb in secretory cells of the ileum and colon.
Interestingly, the expression of trefoil-factor 3 (Tff3), which is important for intestinal tissue repair44, and of 
Peptide YY, which is expressed by enteroendocrine cells and mediates communication with the central nerv-
ous system to induce satiety45, were also reduced in the knockout. For the most part, genes that participate 
in autophagy or lysosomal biogenesis appeared to be unaffected, which could be a result of the action of the 
TFEB-related transcription factor Tfe346. Whether Tfe3 is capable of compensating for the loss of TFEB in the 
intestinal epithelium for the expression of autophagy and lysosomal genes is an important question that requires 
further examination. Overall, these results show that TFEB is required in the intestine for the expression of genes 
that participate in antimicrobial defense, tissue repair, and appetite control.
The loss of APOA1 expression that we observed in unperturbed TfebΔIEC mice could explain, at least par-
tially, their enhanced susceptibility to epithelial injury and colitis. In humans, loss of APOA1 causes familial 
HDL deficiency, Tangier disease, and familial visceral amyloidosis47. APOA1 expression is reduced in Crohn’s 
disease patients, and APOA1 levels inversely correlate with disease activity38,48. Furthermore, APOA1 transcrip-
tion is reduced in the ileal intestinal epithelium of pediatric CD patients, and is part of a specific transcriptional 
signature for that population38,39. Recent studies showed that APOA1-deficient mice exhibit greatly enhanced 
susceptibility to DSS colitis and colitis associated carcinoma, establishing a causal link between APOA1 status 
and intestinal inflammation in mammals40. Furthermore, overexpression of human APOA1 is sufficient to pro-
tect mice from DSS colitis41. The exact molecular mechanism by which APOA1 protects against epithelial injury 
and malignancy is unknown. One proposed mechanism involves sequestration of LPS by HDL, thus reducing 
pro-inflammatory signaling through TLR449. Because TfebΔIEC mice express greatly reduced levels of APOA1 in 
their intestinal epithelium, it is possible that their lack of APOA1 results in higher levels of LPS leakage during the 
initial stages of DSS induction, resulting in more severe inflammation and non-resolving tissue damage. Thus, we 
document a novel role for TFEB in the expression of APOA1, a known protective factor against epithelial injury 
and colitis in rodents and humans.
The importance of TFEB and related transcription factors in inflammation and immunity is emerging. Both 
TFEB and TFE3 were shown to be activated by LPS in macrophages, and to directly trigger a sizable portion of the 
downstream transcriptional response46. Among the genes that are affected by TFEB and TFE3 deletion are IL-6 
and TNFα, which are major contributors to intestinal inflammation in vivo11,46. In addition, TFEB was shown to 
be activated in macrophages during Fc receptor-mediated phagocytosis, and in dendritic cells during treatment 
with LPS50,51. In this context, TFEB is important for antigen cross-presentation with important consequences for 
the adaptive immune response. Finally, TFEB was shown to be involved in a lysosomal homeostatic mechanism 
mediated by Cathepsin B during F. novicida infection in macrophages52. It is important to determine the contri-
bution of TFEB to immune homeostasis and host defense against diverse challenges, including epithelial injury, 
in vivo. From the present study, it is apparent that TFEB exerts an important function in intestinal epithelial cells 
to ensure proper Paneth cell function and protect the intestinal epithelium from injury.
Experimental Procedures
Mice. Mice were bred in specific-pathogen-free facilities at Massachusetts General Hospital. All experi-
ments were conducted following protocols approved by the animal ethics committees at Massachusetts General 
Hospital. Mice expressing cre recombinase under control of the villin promoter (Villin-cre) were purchased from 
Jackson Laboratory. Tfebflox/flox mice18 were obtained from Telethon Institute of Genetic Medicine in Naples, Italy. 
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These mice were bred with Villin-cre mice to create mice with conditional targeted deletion of Tfeb gene. All the 
mice were 8–12 weeks old at the time of all the experiments.
Tissue preparation for immunofluorescence. Mice were sacrificed by CO2 asphyxiation. Pieces of small 
intestine and colon were quickly dissected, opened longitudinally and washed in PBS. 4% paraformaldehyde 
(WAKO) was used for fixation. Fixed tissues were immersed in PBS containing 30% sucrose (Sigma-Aldrich) for 
overnight, embedded in OCT compound (Sakura Finetek USA) and frozen at −80 °C. 8 μm sections were cut 
using Leica CM3050 cryostat (Leica Microsystems) and mounted on microscope slides.
Immunofluorescence staining. Sections were air-dried and microwaved for 10 min in 10 mM citrate 
buffer. 10% donkey serum was used for blocking during staining. Sections were then incubated with diluted 
primary antibody as described below for 18 hours at 4 °C. Slides were washed 3 times in PBS for 5 min and then 
incubated with diluted secondary antibody for 1 h at room temperature. Slides were washed in PBS again and 
mounted in Vectashield medium with DAPI (Vector Laboratories). The primary antibodies used were rabbit 
anti-TFEB (1:250, Bethyl Laboratories), mouse anti-Ki-67 (1:1000, EBIOSCIENCE), rabbit anti-lysozyme 
(1:1000, DACO) and rabbit anti-apolipoprotein A1 Antibody (1 ug/ml, Invitrogen). The secondary antibodies 
used were donkey anti-Rabbit Alexa488 (1:200, Jackson Immunoresearch), donkey anti-Mouse Alexa488 (1:200, 
Jackson Immunoresearch), and donkey anti-Rabbit Alexa 594 (1:200, Jackson Immunoresearch). Images were 
collected using a confocal fluorescent microscope (Nikon, Melville, NY).
IEC isolation. IEC isolation was performed as previously described31. Briefly, ileum and colon were 
removed and separated, opened longitudinally, washed with PBS and further minced into pieces. Tissues were 
treated with 1 mM DTT in PBS for 10 min and further treated with 30 mM EDTA (Boston BioProduct) in PBS 
for 30 min at room temperature. Isolated IECs were collected by centrifuge and used for Western blot or RNA 
analysis.
HE/PAS staining. A piece of small intestine and colon were harvested and quickly fixed in 10% formalin 
overnight at 4 °C. Fixed tissues were embedded in paraffin and 5 μm section was stained with Hematoxylin/Eosin 
(HE) or Periodic acid Schiff (PAS). The number of goblet cells was quantified by counting PAS-positive cells of at 
least 20 villi from 3 individual mice.
Quantification of Immunofluorescence staining. Number of positive staining cells was counted by 
analyzing randomly selected 20 crypts from at least 3 independent mice. Analyzer was blinded to the origin of 
tissues. Fluorescence intensity measurement was done using ImageJ software (NIH) thresholding tool in region 
of interest with the help of ROI Manager. Staining and image acquisition performed in parallel for the entire set 
with identical image acquisition settings and exposure times.
Electron microscopy. Area of electron-dense core (ED) and an electron-lucent peripheral halo (EL) 
in each secretory granule was measured using ImageJ software (NIH). The percentage of granules with EL/
ED + EL ≥ 40% was reported as abnormal granule percentage.
DSS treatment. Littermates with gender matched controls were used for all DSS experiments. Mice were 
fed 2.25% DSS (MW = 40000) dissolved in sterile water for 5 consecutive days, followed by being fed with sterile 
water for 6 additional consecutive days. Body weight of each mouse was measured daily. Disease activity indices 
were measured daily. The following scoring system was used for the daily activity index: Stool consistency: 0; 
normal stool, 1; soft stool, 2; very soft stool, 3; diarrhea, Stool blood content: 0; negative hemoccult: 1; positive 
hemoccult: 2; traces of blood: 3; visible rectal bleeding. Stool consistency and blood content scores were then 
combined. On day 11 after initial treatment of DSS, mice were sacrificed and colon length was measured. Distal 
colon was dissected for HE staining and RNA isolation. Colon histology was scored based on scoring system as 
previously described22. Briefly, severity of inflammation (0–3), depth of injury (0–3), and crypt damage (0–4) 
were estimated, then total scores were multiplied by a factor representing the percentage of tissue involvement: 
×1 (0–25%), ×2 (26–50%), ×3 (51–75%), ×4 (76–100%).
Western blot analysis. Cells were lysed in RIPA buffer (Boston BioProduct) with Complete protease inhib-
itor (Roche) and Phosphatase inhibitor cocktail (Cell Signaling) for 15 min on ice. Lysates were pelleted and used 
for western blotting. The antibodies used were rabbit anti-TFEB (1:1000, Bethyl Laboratories), mouse anti-β-actin 
(1:5000, SIGMA).
Real-time Quantitative PCR. RNA isolation was performed using the RNeasy kit (Qiagen). 
cDNA was synthesized using iScript cDNA Synthesis Kit (BioRad). Quantitative PCR reaction was run 
using the iQ SYBR Green Supermix (BioRad) and the CFX384 Touch Real-Time PCR Detection System 
(BioRad). Relative quantification was performed by normalizing to the expression of reference genes 
Hprt or Gapdh. Primers used were as follows: mouse Tfeb Fwd: TGAGATGCAGATGCCTAACACGCT, 
Rev: TTGTCTTTCTTCTGCCGCTCCTTG, mouse Il1b  Fwd: ACCTCACAAGCAGAGCACAA, 
Rev :  T TGGCCGAGGACTAAGGAGT, mouse I l6  Fwd:  TAGCTATGGTACTCCAGAAGAC, 
Rev :  ACGATGATGCACT TGCAGAA, mouse  Ifng  Fwd:  ATGAACGCTACACACTGCATC, 
Rev: CCATCCTTTTGCCAGTTCCTC, mouse Il17 Fwd: TTTAACTCCCTTGGCGCAAAA, Rev: CTTTCCCTCCGC 
ATTGACAC, mouse Hprt Fwd: AGTCCCAGCGTCGTGATTAG, Rev: TGATGGCCTCCCATCTCCTT, 
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mouse Gapdh Fwd: CATCACTGCCACCCAGAAGACTG, Rev: ATGCCAGTGAGCTTCCCGTTCAG. 
Apoa1 Fwd: GGCAGAGACTATGTGTCCCAGT, Rev: GCTGACTAACGGTTGAACCCAG. Defa25 
Fwd: GTGAAGATCTGATATGCTATTG, Rev: ACCAGAGCATGTACATTAAATG. Defa26  Fwd: 
TACTGAGGTGCAGCCACAGGAA, Rev: GCCTCTTTTTCTACAATAGCATCC.
RNAseq. Intestinal epithelial cells were isolated from the colons of 8–12 week old mice at 0, 4, and 11 days 
post-DSS treatment. For each timepoint, 2 TfebΔIEC and 2 Tfebflox/flox animals were used as biological replicates. 
RNA was extracted by tissuelyzer treatment followed by RNeasy (Qiagen). Full length cDNA libraries were pre-
pared using template switching and whole transcriptome amplification in a slight variation of the SmartSeq. 
2 protocol described in53. Libraries were sequenced on a MiSeq machine (Illumina). Paired-end reads were 
mapped to the mm10 reference genome using Tophat2+ Bowtie. Differential gene expression was determined 
using Cuffdiff54. A corrected p-value (q-value) of 0.05 was considered significant. Mapped reads were deposited in 
GEO with accession number GSE98266. Clustering analysis of differentially expressed genes was performed using 
Pearson correlation implemented in Morpheus (software.broadinstitute.org/morpheus). GO enrichment analysis 
was performed for each gene cluster using g:profiler55.
Measurement of inflammation markers by ELISA and LAL assay. Spleen was homogenized in 
homogenizing buffer (100 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1% Triton X-100, 0.5% 
Sodium deoxycholate), the homogenate was centrifuged and supernatants were used for cytokine measurements 
using mouse IL-1β ELISA kit (eBioscience, 88-7013-22) according to the manufacturer’s protocols, and read 
on a Luminex machine. In order to assess intestinal inflammation, fecal samples from day 1, 4, and 7 post-DSS 
treatment were homogenized in homogenizing buffer, spun down and supernatants were collected and assayed 
for Lipocalin-2 by ELISA according to manufacturer’s instructions (R&D, MLCN20). Serum endotoxin level was 
measured using ToxinSensor Chromogenic Endotoxin Assay Kit (GenScript, L00350). Briefly, diluted plasma 
was incubated with Limulus amoebocyte lysate (LAL) and after performing several reactions under endotoxin 
free condition; samples were read spectrophotometrically at 545 nm. The plasma endotoxin levels were calcu-
lated against a standard curve of endotoxin (E. coli 0113:H10) concentrations of 0.1, 0.05, 0.025, 0.0125 and 0 
EU/ml.
Measurement of CFU in organs. Mesenteric lymph nodes (MLNs) and spleen were aseptically retrieved 
from mice at day 11. Tissue was homogenized in sterile PBS and plated onto LB agar plates after serial dilution, 
then incubated at 37 °C for 24 h before colony forming unit (CFU) quantification.
FITC dextran permeability. Mice were given FITC-dextran tracer (Sigma, 4 kDa, 0.6 mg/g body weight 
in 0.2 mL PBS) via intragastric administration using a ball tip needle and FITC levels were measured 4 h later in 
hemolysis-free serum using a Fluorescence Spectrophotometer.
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